Volume 3, Supplement 2SupplementProstate Cancer Pathology, Screening, and EpidemiologyGary J MillerFernand LabrieJoseph BatuelloE David CrawfordLeonard Michael GlodeDaisaku HiranoProstate cancerPSAPhenotypingMetastatic cascadeDRETRUS
Volume 3, Supplement 2SupplementProstate Cancer: Serum and Tissue MarkersGary J MillerJ Brantley ThrasherWael A SakrRonald TownsendMichael K BrawerProstate-specific antigenDNA ploidyE-cadherinVitamin D receptors
Volume 3, Supplement 2SupplementComplementary Medicine for Prostate Cancer: Effects of Soy and Fat ConsumptionGary J MillerWael A SakrMark A MoyadDaisaku HiranoProstate cancerComplementary medicineFatSoyAlternative medicine
Volume 3, Supplement 2SupplementProstate Cancer: Risk Assessment and Diagnostic ApproachesFernand LabrieEduard J GamitoLeonard G GomellaMichael K BrawerProstate cancerProstate biopsyIGF-ISusceptibility genesTransrectal
Volume 3, Supplement 2SupplementTherapeutic Strategies for Localized Prostate CancerJoseph BatuelloAndrew B JoelJoel KaufmanJohn LynchE David CrawfordLeonard G GomellaDaniel P PetrylakProstate cancerErectile dysfunctionHormonal therapyProstatectomy, radical
Volume 3, Supplement 2SupplementAndrogen Deprivation and Other Treatments for Advanced Prostate CancerPaul D MillerFernand LabrieArturo Mendoza-ValdesE David CrawfordMichael K BrawerDaniel P PetrylakProstate cancerQuality of lifeHormone therapyAndrogen blockade
Volume 3, Supplement 2SupplementNew Approaches to the Treatment of Prostate CancerGeorge StarkJ Brantley ThrasherGary J MillerLeonard Michael GlodeEric GoluboffDaisaku HiranoHormone-refractory prostate cancerNeuroendocrine cellsExisuland
Volume 3, Supplement 1SupplementThe Prevalence of Urinary IncontinenceVictor W NittiUrge incontinenceIncontinenceEpidemiologyEtiologyPrevalenceIncidence
Volume 3, Supplement 1SupplementEvalutating the Effectiveness of Therapies for Urinary IncontinenceRoger R DmochowskiOveractive bladderUrinary incontinenceVoiding dysfunctionUrodynamic